SCHEMBL8615259

SCHEMBL8615259

CCCCS(=O)(=O)Nc1cccc2nc(-c3ccccc3)cc(C(=O)NC(=N)N)c12

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TACR3 P29371 3/20 0.42
MRGPRX1 Q96LB2 1/20 0.41
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
ALOX12 P18054 1/20 0.40
CYP2C19 P33261 1/20 0.40
KMT2A Q03164 1/20 0.40
KDM4E B2RXH2 2/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
DHODH Q02127 1/20 0.39
PLA2G2A P14555 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8614946 0.92 ALDH1A1 (0.43) TACR3ALDH1A1MEN1CYP1A2CYP3A4
SCHEMBL8615326 0.86 MEN1 (0.45) TACR3ALDH1A1MEN1CYP1A2CYP3A4
SCHEMBL8620920 0.82 TACR3 (0.43) TACR3
SCHEMBL8617855 0.81 DHODH (0.47) TACR3ALDH1A1MEN1CYP1A2CYP2C9
SCHEMBL8619780 0.81 ADORA3 (0.47) TACR3ALDH1A1MEN1CYP1A2CYP3A4
SCHEMBL8613501 0.80 CA9 (0.45) TACR3ALDH1A1MEN1CYP3A4KMT2A
SCHEMBL8614054 0.80 KMT2A (0.51) TACR3ALDH1A1MEN1CYP1A2CYP3A4
SCHEMBL8618942 0.79 ACLY (0.45) TACR3ALDH1A1MEN1CYP1A2CYP3A4
SCHEMBL8617819 0.79 ACLY (0.42) TACR3ALDH1A1MEN1CYP1A2CYP3A4
SCHEMBL8618116 0.78 ADORA1 (0.47) TACR3ALDH1A1MEN1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0726254-B1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS (JP) 1998-05-06 EP disclosed
US-5627193-A MEDICAL DIAGNOSIS, CARDIOVASCULAR DIAORDERS AND PROTECTION OF ORGANS FOR TRANSPLANTATION MITSUI TOATSU CHEMICALS, INC. (JP) 1997-05-06 US disclosed
EP-0726254-A1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-08-14 EP disclosed